AUROPHARMA swing trade setup
Aurobindo Pharma Ltd. · Healthcare · NSE cash equity
Trend structure
Relative strength vs NIFTY
| Period | AUROPHARMA | NIFTY | Excess |
|---|---|---|---|
| 1M | +2.67% | -3.86% | +6.53% |
| 3M | +16.40% | +1.81% | +14.59% |
| 6M | +38.07% | -4.57% | +42.63% |
Over the last year AUROPHARMA has traded between ₹1,021 and ₹1,717, and currently sits 96% of the way up that range.
AUROPHARMA passes none of the 3 AI swing screeners right now
Not every stock is a trade, and EdgeScan says so rather than finding a reason. Premium shows the rule-by-rule reasoning for exactly which conditions it failed, plus every stock that is setting up right now.
Swing screeners that scan AUROPHARMA
Every screener publishes its exact rules, its full backtest and its worst trade before you subscribe. Browse all screeners or read the backtest methodology.
Not investment advice. EdgeScan is an analytics and screening tool - the figures above are mechanical readings of public price data and are for educational purposes only. Past and backtested performance does not guarantee future results.